Xiamen Amoytop Biotech Co., Ltd.

This study tests a new drug called inpegsomatropin in 36 adults with growth hormone deficiency. Participants receive either the drug or a placebo to check safety and how well it works. The goal is to see if the drug can safely replace missing growth hormone and improve body compo…

This early-stage trial tests a new oral drug called ACT500 in 24 adults with metabolic fatty liver disease (MASLD). The main goal is to check safety and how the drug moves through the body. Participants take one pill daily, and doctors monitor for side effects and measure drug le…